Keythera (Suzhou) Biopharmaceuticals Co., Ltd.

Keythera, founded in 2020, is a clinical-stage biotech firm focused on pioneering small molecule drugs that effectively combat cancers and autoimmune disorders. The company's founder and core team members possess vast expertise in the field of drug discovery and development research. To build a robust portfolio of products, the company employs a strategy that leverages its affinity based high throughput screening technological platform. By doing so, the company aims to expedite the process of discovering and developing new drugs while also ensuring distinctiveness within its product pipelines.